This observational study is following people with schizoaffective disorder, Depressive Type, bipolarity I, or bipolarity II to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
In Nantes
Bipolarity, Schizophrenia, ...BiologicalOver 18 Years
This study is comparing Methylphenidate with placebo for people with Attention Deficit Hyperactivity Disorder Combined. Participants receive Methylphenidate or placebo and complete study visits and assessments.
Multiple locations, including Baltimore
ADHDDrugA study involving a medication or substance.From 8 Years to 12 Years
This study is looking at whether a digital support tool can help people with Treatment Resistant Depression or depression. Participants take part in a digital support tool and complete follow-up assessments.
Multiple locations, including Stanford
DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 22 Years to 65 Years
This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand what blood tests and biological markers can reveal about signals in the brain or body that may guide care later on.
This observational study is following people with Schizophrenia or Psychosis to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at whether rTMS therapy can help people with major depression. Participants take part in rTMS therapy and complete follow-up assessments.
This study is looking at whether Recorded interview can help people with First-episode Psychosis. Participants receive a study treatment and complete follow-up visits and assessments.
This study exists to see whether cognitive behavioural therapy, a structured talking treatment, is workable and worth testing more broadly. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.
This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand whether blood tests and biological markers can give earlier or clearer feedback during care.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.